Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ex vivo assays to detect complement activation in complementopathies

Clinical Immunology(2020)10.1016/j.clim.2020.108616Source: DataRank Database

Ex vivo assays to detect complement activation in complementopathies is a research paper published in Clinical Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.72)OA: greenTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Jia Yu ORCID,Gloria F. Gerber ORCID,Shruti Chaturvedi ORCID,Michael Cole ORCID,Hang Chen ORCID

Live enrichment

PubMed:33148511 PMC:PMC8609776 OpenAlex:https://openalex.org/W3094633332

National Heart, Lung, and Blood Institute

Grant: R01HL133113 2016

National Heart, Lung, and Blood Institute

Grant: K08 HL138142

NHLBI NIH HHS

Grant: R01 HL133113

FWCI

0.72

Citation Percentile

0.7%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8609776

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609776

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8609776

publisherhttps://api.elsevier.com/content/article/PII:S1521661620307762?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1521661620307762?httpAccept=text/plain

Fields of Study

Complement system in diseasesRenal Diseases and GlomerulopathiesPlatelet Disorders and TreatmentsChemistryMedicineAdultAntiphospholipid SyndromeAtypical Hemolytic Uremic SyndromeBiological AssayCell Line, TumorComplement ActivationComplement C3cComplement C4bComplement Inactivating AgentsComplement Membrane Attack ComplexElapid VenomsFemaleHumansLipopolysaccharidesMaleMiddle AgedNeuraminidasePeptide FragmentsShiga Toxin 1

MeSH Terms

AdultBiological AssayComplement ActivationElapid VenomsFemaleHumansLipopolysaccharidesMaleMiddle AgedNeuraminidasePeptide FragmentsComplement C3cComplement C4bComplement Membrane Attack ComplexAntiphospholipid SyndromeShiga Toxin 1Cell Line, TumorComplement Inactivating AgentsAtypical Hemolytic Uremic Syndrome

Keywords

Complement systemAlternative complement pathwayComplement factor BFactor HComplement component 5AntibodyEx vivoIn vitroIn vivoImmunologyBiologyBiochemistryComplementSialidaseAtypical Hemolytic Uremic SyndromeComplement InhibitorsShiga Toxin 1Modified Ham Assay

Sustainable Development Goals

SDG 0: Good health and well-being

Ex vivo assays to detect complement activation in complementopathies

FAIR Checklist

Authors (10)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)